Mylan's Bid For Perrigo Leading To a $700 Million Payday For Abbott Labs

MarketWatch Pulse

Investors in Perrigo Co. PLC aren't the only ones doing cartwheels after Mylan N.V.'s buyout proposal. Abbott Laboratories owns 75 million, or 15.4%, of Mylan's shares, which makes Abbott the largest shareholder in its fellow drug maker. With Mylan's stock up $9.40, or 16%, at an all-time high in midday trade, Abbott is making $705 million on its investment on the day. Abbott's stock was up 0.8%, and has gained 3.4% year to date, while the S&P 500 advanced 1.1%. Meanwhile, Perrigo's stock was up $37.46, or 23%, which adds $5.51 billion to the drug maker's market capitalization.

Copyright © 2015 MarketWatch, Inc.

Continue Reading Below